European Journal of Nutrition

, Volume 52, Issue 5, pp 1513–1521

Riboflavin depletion of intestinal cells in vitro leads to impaired energy generation and enhanced oxidative stress

  • Eun-Sook Lee
  • Bernard M. Corfe
  • Hilary J. Powers
Original Contribution



Riboflavin is an essential component of the human diet, with an established role for its derivative cofactors in oxidative metabolism. Our previous in vivo data suggest that riboflavin may act as a signalling molecule in the intestinal lumen, regulating crypt development and cell turnover. Our in vitro studies in riboflavin-depleted intestinal cells in culture indicate that riboflavin depletion impairs normal mitosis.


The aim of the study was to establish an improved intestinal cell model of riboflavin depletion using the structural analogue of riboflavin, lumiflavin (7,8,10-trimethyl-isoalloxazine) and to determine effects on cell function. The study was conducted using three intestinal cell lines, Caco-2, HCT116 and HT29 cells.


Cell growth was inhibited in all three cell lines, in a lumiflavin concentration-dependent manner. Riboflavin depletion was confirmed through a significant decrease in intracellular riboflavin concentrations in Caco-2 and HT29 cell lines and a significant increase in the activation coefficient for the flavin adenine dinucleotide-dependent enzyme glutathione reductase. Riboflavin depletion led to a significant reduction in intracellular ATP concentration, and an enhanced generation of reactive oxygen species was also observed in response to riboflavin depletion, in all cell lines; effects were at least fivefold greater in Caco-2 cells than other cells. Riboflavin-depleted Caco-2 and HCT116 cells also showed an irreversible loss of proliferative potential.


A model system of intracellular riboflavin depletion in intestinal epithelial cells has been developed. Riboflavin depletion induced by lumiflavin results in oxidative stress and a disruption of energy generation, which may contribute to observed effects on cell proliferation.


Riboflavin deficiency Lumiflavin Intestinal epithelial cells ATP ROS Clonogenicity 


  1. 1.
    Gastaldi G, Ferrari G, Verri A, Casirola D, Orsenigo MN, Laforenza U (2000) Riboflavin phosphorylation is the crucial event in riboflavin transport by isolated rat enterocytes. J Nutr 130(10):2556–2561Google Scholar
  2. 2.
    Powers HJ (2003) Riboflavin (vitamin B-2) and health. Am J Clin Nutr 77(6):1352–1360Google Scholar
  3. 3.
    Olpin SE, Bates CJ (1982) Lipid metabolism in riboflavin-deficient rats. 2. Mitochondrial fatty acid oxidation and the microsomal desaturation pathway. Br J Nutr 47(3):589–596CrossRefGoogle Scholar
  4. 4.
    Prentice AM, Bates CJ (1981) A biochemical evaluation of the erythrocyte glutathione reductase (EC test for riboflavin status. 2. Dose-response relationships in chronic marginal deficiency. Br J Nutr 45(1):53–65CrossRefGoogle Scholar
  5. 5.
    Gregory J, Lowe S (2000) National diet and nutritional survey (NDNS): young people aged 4–18 years. The Stationery Office, London.
  6. 6.
    Bates CJ, Prentice A, Cole TJ, van der Pols JC, Doyle W, Finch S et al (1999) Micronutrients: highlights and research challenges from the 1994–1995 National Diet and Nutrition Survey of people aged 65 years and over. Br J Nutr 82(1):7–15Google Scholar
  7. 7.
    Williams EA, Powers HJ, Rumsey RD (1995) Morphological changes in the rat small intestine in response to riboflavin depletion. Br J Nutr 73(1):141–146CrossRefGoogle Scholar
  8. 8.
    Williams EA, Rumsey RD, Powers HJ (1996) Cytokinetic and structural responses of the rat small intestine to riboflavin depletion. Br J Nutr 75(2):315–324CrossRefGoogle Scholar
  9. 9.
    Williams EA, Rumsey RD, Powers HJ (1996) An investigation into the reversibility of the morphological and cytokinetic changes seen in the small intestine of riboflavin deficient rats. Gut 39(2):220–225CrossRefGoogle Scholar
  10. 10.
    Yates CA, Evans GS, Powers HJ (2001) Riboflavin deficiency: early effects on post-weaning development of the duodenum in rats. Br J Nutr 86(5):593–599CrossRefGoogle Scholar
  11. 11.
    Yates CA, Evans GS, Pearson T, Powers HJ (2003) Absence of luminal riboflavin disturbs early postnatal development of the gastrointestinal tract. Dig Dis Sci 48(6):1159–1164CrossRefGoogle Scholar
  12. 12.
    Nakano E, Mushtaq S, Heath PR, Lee ES, Bury JS, Riley SA et al (2011) Riboflavin depletion impairs cell proliferation in adult human duodenum: identification of potential effectors. Dig Dis Sci 56:1007–1019CrossRefGoogle Scholar
  13. 13.
    Alcantara-Torres M, Rodriguez Merlo R, Repiso Ortega A, de Lucas Veguillas A, Vallez Munoz J, Sanchez Simon R et al (2005) DNA aneuploidy in colorectal adenomas. Role in the adenoma-carcinoma sequence. Rev Esp Enferm Dig 97(1):7–15CrossRefGoogle Scholar
  14. 14.
    Ekbom A, Helmick C, Zack M, Adami HO (1990) Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 323(18):1228–1233CrossRefGoogle Scholar
  15. 15.
    Karaman A, Binici DN, Kabalar ME, Calikuşu Z (2008) Micronucleus analysis in patients with colorectal adenocarcinoma and colorectal polyps. World J Gastroenterol 14(44):6835–6839CrossRefGoogle Scholar
  16. 16.
    Rosman-Urbach M, Niv Y, Birk Y, Smirnoff P, Zusman I, Morgenstern S, Schwartz B (2004) A high degree of aneuploidy, loss of p53 gene, and low soluble p53 protein serum levels are detected in ulcerative colitis patients. Dis Colon Rectum 47(3):304–313CrossRefGoogle Scholar
  17. 17.
    Willenbucher RF, Zelman SJ, Ferrell LD, Moore DH 2nd, Waldman FM (1997) Chromosomal alterations in ulcerative colitis-related neoplastic progression. Gastroenterology 113(3):791–801CrossRefGoogle Scholar
  18. 18.
    Willenbucher RF, Aust DE, Chang CG, Zelman SJ, Ferrell LD, Moore DH 2nd, Waldman FM (1999) Genomic instability is an early event during the progression pathway of ulcerative-colitis-related neoplasia. Am J Pathol 154(6):1825–1830CrossRefGoogle Scholar
  19. 19.
    Said HM, Ma TY (1994) Mechanism of riboflavine uptake by Caco-2 human intestinal epithelial cells. Am J Physiol 266(1 Pt 1):G15–G21Google Scholar
  20. 20.
    Said HM, Ortiz A, Moyer MP, Yanagawa N (2000) Riboflavin uptake by human-derived colonic epithelial NCM460 cells. Am J Physiol Cell Physiol 278(2):C270–C276Google Scholar
  21. 21.
    Yamamoto S, Inoue K, Ohta KY, Fukatsu R, Maeda JY, Yoshida Y, Yuasa H (2009) Identification and functional characterization of rat riboflavin transporter 2. J Biochem 145(4):437–443CrossRefGoogle Scholar
  22. 22.
    Yonezawa A, Masuda S, Katsura T, Inui K (2008) Identification and functional characterization of a novel human and rat riboflavin transporter, RFT1. Am J Physiol Cell Physiol 295(3):C632–C641CrossRefGoogle Scholar
  23. 23.
    Capo-chichi CD, Gueant JL, Feillet F, Namour F, Vidailhet M (2000) Analysis of riboflavin and riboflavin cofactor levels in plasma by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 739(1):219–224CrossRefGoogle Scholar
  24. 24.
    Powers HJ (1999) Current knowledge concerning optimum nutritional status of riboflavin, niacin and pyridoxine. Proc Nutr Soc 58(2):435–440CrossRefGoogle Scholar
  25. 25.
    Hill MHH, Bradley A, Mushtaq S, Williams EA, Powers HJ (2009) Effects of methodological variation on assessment of riboflavin status using the erythrocyte glutathione redeuctase activation coefficient assay. Br J Nutr 102(2):273–278CrossRefGoogle Scholar
  26. 26.
    Werner R, Manthey K, Griffin JB, Zempleni J (2005) HepG2 cells develop signs of riboflavin deficiency within 4 days of culture in a riboflavin-deficient medium. J Nutr Biochem 16(10):617–624CrossRefGoogle Scholar
  27. 27.
    Lee S-S, McCormick DB (1983) Effect of riboflavin status on flavin-metabolising enzymes in rats. J Nutr 113:2274–2279Google Scholar
  28. 28.
    Yamada Y, Merrill AH, McCormick DB (1990) Probable reaction mechanisms of flavokinase and FAD synthetase from rat liver. Arch Biochem Biophys 278(1):125–130CrossRefGoogle Scholar
  29. 29.
    Burch HB, Lowry OH, Bradley ME, Max P Jr (1970) Hepatic metabolites and cofactors in riboflavin deficiency and calorie restriction. Am J Physiol 219(2):409–415Google Scholar
  30. 30.
    Van’t Hof J (1968) Control of cell progression through the mitotic cycle by carbohydrate provision. J Cell Biol 37:773–780CrossRefGoogle Scholar
  31. 31.
    Scaife RM (2004) G2 cell cycle arrest, down-regulation of cyclin B, and induction of mitotic catastrophe by the flavoprotein inhibitor diphenyleneiodonium. Mol Cancer Ther 3(10):1229–1237Google Scholar
  32. 32.
    Shackelford RE, Kaufmann WK, Paules RS (2000) Oxidative stress and cell cycle checkpoint function. Free Radic Biol Med 28(9):1387–1404CrossRefGoogle Scholar
  33. 33.
    Tumkiratiwong P, Tungtrongchitr R, Migasena P, Pongpaew P, Rojekittikhun W, Vudhivai N et al (2003) Antioxidant enzyme levels in the erythrocytes of riboflavin-deficient and Trichinella spiralis-infected rats. Southeast Asian J Trop Med Publ Health 34(3):480–485Google Scholar
  34. 34.
    Collett A, Sims E, Walker D, He Y, Ayrton J, Rowland M, Warhurst G (1996) Comparison of HT29-18-C1 and Caco-2 cell lines as models for studying intestinal paracellular drug absorption. Phar Res 13(2):216–221CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • Eun-Sook Lee
    • 1
  • Bernard M. Corfe
    • 2
  • Hilary J. Powers
    • 1
  1. 1.Human Nutrition Unit, Department of Oncology, Faculty of Medicine, Dentistry and HealthUniversity of SheffieldSheffieldUK
  2. 2.Molecular Gastroenterology Research Group, Academic Unit of Surgical Oncology, Department of Oncology, Faculty of Medicine, Dentistry and HealthUniversity of SheffieldSheffieldUK

Personalised recommendations